1. Introduction {#sec1}
===============

Reactions of protein phosphorylation and dephosphorylation play a significant regulatory role in cell processes. Activity of many proteins, such as regulatory proteins, histones, permeases of various compounds, and plenty of enzymes, depends on working of protein kinases and phosphatases.

Phosphorus is known to be one of the most necessary macroelements, used in biosynthesis of the most important cell macromolecules, such as nucleic acids, proteins, and lipids. Reducing the level of inorganic phosphate (*P*~*i*~) in medium leads to changes of cell physiology, influences on ATP synthesis, DNA replication, and other key processes in the cell \[[@B1]\]. In case of phosphate shortage, the cell can replace it by different phosphate-containing organic compounds, which undergo the cleavage of ether bonds by the phosphatases that results in release of *P*~*i*~ and its subsequent importation into the cell. Most of the genes encoding phosphatases are activated and repressed concordantly depending on *P*~*i*~ concentration in the medium. The special positive and negative regulators in and out of cell transduce the signals about that \[[@B2]\].

The budding yeast *Saccharomyces cerevisiae* appeared to be the most convenient object for researching structure and functions of the phosphatases. Family of nonspecific acid phosphatases is one of the most popular molecular models in yeast genetics that gives unique opportunities for investigating different functions of phosphatases and protein kinases.

2. Phosphate Metabolism {#sec2}
=======================

In living organisms, the phosphate is present basically in the form of orthophosphate (HPO~4~ ^2−^). In the yeast, *P*~*i*~ can be found as free ion, but the most part of it is bound in phospholipids, nucleotides, phosphoproteins, and phosphorylated hydrocarbons. An excess of *P*~*i*~ is accumulated in the form of polyphosphates, which represent linear polymers of orthophosphoric acid. The polyphosphate comprises phosphate atoms linked by anhydride bonds that results in its capability of storing energy and releasing it by the bonds\' hydrolysis \[[@B3]\]. Also *P*~*i*~ has an important role in the intracellular pH maintenance. Beside this, *P*~*i*~ acts as a substrate and an effector for many enzymes (for example, phosphofructokinase) and regulates many metabolic pathways. Reaction speed alterations of any process leading to *P*~*i*~ release or its consumption affect the level of intracellular *P*~*i*~. Decrease of *P*~*i*~ quantity in the medium and in the cell can be compensated by using the intracellular phosphate resources as ATP, phosphoenolpyruvate, sugar phosphates, and polyphosphates \[[@B4]\]. Analysis of almost 6200 yeast genes revealed 22 genes whose expression is sharply increased for the lack of phosphate. This gene group was designated as *PHO*-regulon. Also *P*~*i*~ concentration influences on the expression of many other genes, which may not participate directly in phosphate metabolism, but their transcription is activated or repressed for the lack of phosphate in the medium \[[@B5]\].

The enzymes of phosphate metabolism include the following: isozymes of the nonspecific acid phosphatase (AP), which provide detachment of phosphate group from the phosphate-containing organic compounds in medium; transport proteins, that is, permeases with different phosphate affinity; alkaline phosphatases; polyphosphatases; polyphosphate kinases; also enzymes with phytase activity \[[@B6]\]. APs of *S. cerevisiae* are of special interest because they being extracellular enzymes are localized in cell wall and periplasmic space that significantly simplifies qualitative and quantitative methods of enzyme activity testing and also procedure of their extraction. Studying AP isozymes of yeast strain GRF18 (Dr. Hinnen, USA) and the strains from Peterhoff Genetic Collection (PGK), St. Petersburg, Russia revealed that yeast *S. cerevisiae* synthesize three isozymes of acid phosphatases designated as AP1, AP2, and AP3 \[[@B7]\]. AP1 is synthesized constitutively, while others are repressed by high phosphate concentration. Fractionating on Sephadex G-200 columns showed that all three AP isozymes (AP1, AP2, and AP3) represent glycoproteins with molecular masses more than 200 kDa ([Figure 1](#fig1){ref-type="fig"}) \[[@B8], [@B9]\]. Molecular masses of the polypeptides after deglycosylation were shown to be 57 kDa for AP1, 58 kDa for AP2, and 55 kDa for AP3 \[[@B9]\]. These results agree with the data of Bostian and coworkers obtained in translation product analysis of the total yeast polyA-RNA in cell-free system \[[@B10]\]. Studying properties of the APs showed that all of them have optimum pH value in acid range and that AP1 has lower optimum pH value near 3,7--3,8 than AP2 and AP3 (pH 4,6) ([Figure 2](#fig2){ref-type="fig"}). This feature provides the ability of hydrolyzing extracellular substrates in periplasmic space.

Constitutive AP1 is more thermostable than repressible APs ([Figure 3](#fig3){ref-type="fig"}). AP1 shows full activity at 40°C, while AP2 maintains 40% of its activity during 15 minutes, and AP3 is almost inactivated at 40°C \[[@B8], [@B9]\].

Exploration of the conditions for repressible APs accumulation in cultural medium revealed that AP3 activity inhibition occurs at the lower concentration of KH~2~PO~4~ than that for AP2 \[[@B9]\] ([Figure 4](#fig4){ref-type="fig"}).

The constitutive AP1 is encoded by gene *PHO3*of *S. Cerevisiae*; it hydrolyses different phosphate-containing substrates in periplasmic space (thiamine pyrophosphates, in particular). The increase of thiamine concentration in medium leads to *PHO3* transcription blockage \[[@B11]\].

Repressible AP2 and AP3, encoded by genes *PHO5* and *PHO10,11,* respectively, are synthesized in conditions of low phosphate only. Therefore, the regulation system of repressible APs is a convenient model for comparable genetic analysis of enzymes biosynthesis mechanisms \[[@B12]\]; In derepression conditions, the APs\' fraction is mainly composed of AP2 (Pho5p), and the minor fraction consists of Pho10p and Pho11p, which have 87% amino acid sequence identity with Pho5p. Genes *PHO3* and *PHO5* are linked in II chromosome of *S. cerevisiae* \[[@B13]\]. The coding regions of both genes have high rate of homology in nucleotide (82%) and amino acid (87%) sequences. This rate decreases to 65% towards flanking noncoding regions and becomes very low in promoter regions of these genes \[[@B14]\]. Genes of acid phosphatases family *PHO3*, *PHO5*, *PHO10,* and *PHO11* are possibly the result of ancestral gene duplication \[[@B15]\].

2.1. Phosphate Transport {#sec2.1}
------------------------

Transmembrane transportation of *P*~*i*~ is the first and obligatory step of its assimilation by cell. Uncombined phosphate is transported into cell by special permeases. There are three transport systems, which depend on concentrations of *P*~*i*~ and also H^+^ and Na^+^ ions. The presence of different transport systems with high and low phosphate affinity provides flexibility for yeast phosphate metabolism in continuously changing environmental conditions. Mutations affecting *P*~*i*~ transport occur in a set of genes: *PHO84, PHO86, PHO87, PHO88, PHO89,*and *GTR1* and still unknown gene encoding low-affinity transporter. Such mutants are characterized by constitutive *PHO5* expression. High-affinity transport system includes two phosphate permeases Pho84p and Pho89p with dissociation constant K~m~\~8 *μ*M \[[@B16], [@B17]\]. Expression of genes *PHO84* and *PHO89* is repressed by phosphate abundance \[[@B18]\].

The main phosphate permease of this system is Pho84p \[[@B16]\]. It has *K*~*m*~ value ranging from 1 to 15 *μ*M and works at pH 4,5. Pho84p is a symporter of H^+^ and symports 2-3 ions with one phosphate. Furthermore, Pho84p was shown to transport selenium \[[@B19]\] and manganese \[[@B20]\]. Pho84p activity is inhibited by arsenate that allows to get selectively mutations *pho84* by picking yeast clones resistant to arsenate \[[@B21]\]. The quantity of Pho84p decreases in case of phosphate concentration increase or carbon source depletion in the medium \[[@B22]\]. Pho84p combines into complexes with some other proteins participating in *P*~*i*~ transport: Pho86p, Pho87p, Pho88p, and Gtr1p. The last one plays a special role: N-terminal domain of Gtrp1p (35,8 kDa) is similar to yeast protein Ypt1p and comprises a region for binding GTP. Gtr1p is a member of *ras* family of GTP binding proteins. Gene *GTR1* is localized in yeast chromosome XIII near gene *PHO84*. The disruption *pho84* leads to constitutive synthesis of APs and affects *P*~*i*~ assimilation by the cell. The complex Gtr1p-Pho84p is supposed to have a regulatory function and to be a receptor of *P*~*i*~ concentration signals \[[@B23]\]. Permease Pho84p is packed to COP II-coated vesicles and transported to the cell surface with the help of Pho86p \[[@B24], [@B25]\].

Another *P*~*i*~ transporter with high affinity is encoded by gene *PHO89*. It has *K*~*m*~ value near 0,5 *μ*M and performs Na^+^-associated *P*~*i*~ cotransportation and works at pH 9,5 \[[@B26]\].

Low-affinity phosphate transport system includes three permeases: Pho87p, Pho90p, and Pho91p with dissociation constant *K*~*m*~ \~ 770 *μ*M \[[@B16]\].

Expression of genes *PHO84*, *PHO89*, *PHO87*, *PHO90,* and *PHO91* is regulated according to the models of positive and negative feedback loops \[[@B18]\]. Low-affinity permeases\' activity is regulated with the participation of protein Spl2p \[[@B27]\]. The expression of genes *PHO84* and *SPL2* is controlled by transcription factor Pho4p whose activity depends on intracellular *P*~*i*~ concentration.

2.2. Genetic Control of AP1 Synthesis {#sec2.2}
-------------------------------------

Transcription rate of gene *PHO3* is regulated by thiamine (vitamin B1), which is a necessary component for enzymatic reactions in Krebs cycle and pentose-phosphate pathway of carbohydrate oxidation. The yeast is able to receive extracellular thiamine from a medium using the special membrane transporter, encoded by gene *THI7*, and also to create its own intracellular thiamine using the enzyme, encoded by gene *THI4* \[[@B28]\]. There are some recessive mutations revealed in *PHO3*, which lead to blocking AP1 activity and changing its properties \[[@B7], [@B29], [@B30]\]. Unlike wild-type yeast cells, *pho3* mutants are characterized by significantly reduced intensity of thiamine pyro- and monophosphates transport. It means that AP1 is responsible for hydrolyzing thiamine phosphates in periplasmic space and is specialized on this class of phosphate-containing compounds \[[@B31]\]. Thiamine addition results in repressing Pho3p activity and thiamine biosynthesis enzymes \[[@B32]\]. *PHO3* expression was shown also to depend on the type of nitrogen source in cultural medium \[[@B33]\]. It was proved that *PHO3* expression level is decreased while yeast cells use poor nitrogen sources like urea \[[@B34]\].

2.3. Genetic Control of Repressible APs Synthesis {#sec2.3}
-------------------------------------------------

The regulation of repressible APs genes\' expression is one of the most well-studied genetic systems in yeast *S. cerevisiae*\[[@B2]\]. The regulation of *PHO5* gene, encoding major repressible AP, differs from *PHO10* and*PHO11* by higher rate of expression during phosphate absence and stringent repression during phosphate abundance \[[@B14]\]. Genes *PHO10* and *PHO11* are the result of duplication \[[@B35]\]. Promotor regions of nonlinked genes *PHO5* and *PHO11* have a strong homology and are regulated in coordination \[[@B36]\]. Because of its accurate regulating mechanism, gene *PHO5* promotor is widely used in biotechnology for industrial production of heterologous proteins in the yeast \[[@B37]\].

There are some recessive mutations revealed in gene *PHO5*, which affect AP2 activity; its deletion leads to growth speed decrease in complete and mineral media \[[@B12], [@B38]\]. Mutations *pho5* occurred in signal peptide damage a secretion level of the protein that was synthesized in cells successfully \[[@B39]\]. Intracellular AP2 represents a dimer \[[@B40]\]; in periplasmic space, APs form an oligomerous enzyme comprising Pho5p, Pho11p, and Pho12p \[[@B41]\].

Nowadays there are multiple levels of gene *PHO5* expression regulation discovered that displays an importance of this gene for the yeast cell \[[@B42]--[@B44]\].

The expression of the genes encoding phosphate metabolism enzymes (*PHO*-regulon) is regulated by transcriptional activators Pho4p and Pho2p, cyclin-CDK complex Pho85p-Pho80p, and inhibitor of cyclin-CDK complex Pho81p \[[@B25], [@B45]\].

Transcription induction of gene *PHO5* is associated with chromatin reorganization in promotor region \[[@B46], [@B47]\]. While in repression conditions (when phosphate is abundant), promotor of *PHO5* gene is packaged into four nucleosomes and only 70 bp region remains unoccupied and nuclease sensitive. Two nucleosomes flank the UAS1 region (5′-AATTAGCACGTTTTCGCCATA-3′) that is unoccupied, while UAS2 (5′-GCACTCACACGTGGGA-3′) and TATA-box are packed into the nucleosomes-2 and -1, respectively \[[@B48]\]. When phosphate concentration is low, activator Pho4p is imported in the nucleus and docks UAS1 and UAS2 regions of promotor. This leads to changing the chromatin structure and nucleosome removal \[[@B49]\]. It was shown that mutations in UAS1 or UAS2 lead to tenfold promotor activity decrease, and double mutations in both regulatory sequences are followed by lack of *PHO5* induction \[[@B50]\].

When extracellular phosphate concentration is high, cyclin-CDK complex Pho85p-Pho80p hyperphosphorylates the transcriptional activator Pho4p that leads to its localization in cytoplasm and inactivation \[[@B51]\]. Free of TFs gene *PHO5* promotor is a target for nucleosomal chaperon Spt6p that restores nucleosome structures in the promotor. Spt6p inhibition results in that *PHO5* promotor stays free of nucleosomes and transcription occurs *in vivo* even in the absence of the activator. Therefore, Pho4p function may be to maintain promotor in nucleosome-depleted state \[[@B52]\]. It was proposed earlier that chromatin remodeling takes place in the absence of DNA replication \[[@B53]\] and requires the presence of Pho4p activating domain \[[@B54]\]. This domain can interact with the transcription apparatus and assist in forming the initiation complex on the promoter only after nucleosomes\' removal \[[@B55]\]. It is remarkable that Spt6p absence and transcription-prone chromatin can be followed by DNA replication \[[@B56]\].

Also SAGA protein complex contributes to *PHO5* expression activation. The attraction of this complex depends on Pho4p activity. Histone acetyltransferase Gcn5p is one of the complex subunits. Deletion *gcn5* leads to nucleosome rearrangements in *PHO5* promotor and drastic reduction of transcription rate \[[@B57]\]. Another member of the SAGA complex is Spt3p. Its functions differ from Gcn5p: deletion *spt3* leads to the reduction of *PHO5* transcription affecting TBP interaction with TATA-box but not touching the chromatin structures. Double mutant *gcn5spt3* displays the same phenotype as mutants *spt7* or *spt20* \[[@B58]\]. They are not able to form the SAGA complex at all. Another subunit is Ada2p, whose absence results in chromatin remodeling delay like in case of mutation *gcn5*. Factor Ada2p controls Gcn5p activity via SANT domain. Thus, the SAGA complex appears to be coactivator of *PHO5* promotor along with Pho4p \[[@B59]\].

2.4. Phosphate Concentration Signals Transduction Pathways {#sec2.4}
----------------------------------------------------------

The AP2 and AP3 synthesis is repressed in response to high concentration of *P*~*i*~. To research transduction pathways for this signal, the mutants were selected characterized by constitutive synthesis of APs. As a result, some more genes were identified in addition to known *PHO2, PHO4, PHO80, PHO85,* and *PHO81*. Gene *PMA1* encodes ATPase of plasma membrane. Gene *ACC1* is involved in fatty acid synthesis. Also a novel, nonessential gene *PHO23* was identified. The mutants *pho84*, *pho86,* and *pma1* are defective in high-affinity phosphate uptake, whereas *acc1* and *pho23*are not. Hence, the products of these genes control different steps of signal transduction about high phosphate concentration to the regulatory factors of *PHO*-regulon expression \[[@B60]\].

Pho84p was shown to be not only high-affinity permease but also a signal transmitter of phosphate and glycerol-3-phosphate quantities. A novel term was proposed for the molecules like, "transceptor" \[[@B61]\].

2.5. Cyclin-Dependent Protein Kinase Pho85p {#sec2.5}
-------------------------------------------

Yeast *S. cerevisiae* is the most well-studied eukaryotic model object for signal transmission and adaptive response molecular mechanisms studies. The main components of signalling networks are well conserved from yeast to higher eukaryotes. The central role in the regulation of signalling cascades in yeast is executed by nutrients, while in higher eukaryotic cells, the same role is played by hormones and growth factors. In yeast *S. Cerevisiae,* several nutrient-controlled pathways which adapt cell growth and proliferation, metabolism, and stress resistance, have been estimated. These pathways form general signalling network which guarantees that yeast cells enter resting phase G~0~ in order to pass through the period of nutrient depletion and, on the other hand, to be capable of cell proliferation fast resumption, when nutrient conditions become favorable. Key roles in this signalling network play nutrient-sensory protein kinases PKA, Snf1p, Tor1p, Tor2p, Sch9p, and Pho85p. Pho85 is a cyclin-dependent protein kinase with a wide range of substrates, which is a functional homologue of Cdk5p \[[@B62]\]. Protein kinase Pho85p takes part in phosphate and glycogen metabolism regulation, autophagy regulation, stress adaptation, proline utilization, regulates proteolysis, and cell polarity.

Cyclin-dependent protein kinases (CDKs) are the group of serine-threonine kinases and have multiple regulatory functions of great importance in such global processes as cell cycle, cell differentiation, and cell response to environmental changes. *S. cerevisiae* CDK family comprises Cdc28p, Ssn3p, Kin28p, Pho85p, and Cak1p \[[@B63]\]. Binding CDK with cyclin protein followed by phosphorylation leads to the activation of catalytic CDK subunits \[[@B64]\]. Cyclins define CDK substrate specificity. Nowadays, ten cyclins Pcl1--10 and at least nineteen substrates (Pho4p, Sic1p, Rvs167p, etc.,) of Pho85p are known \[[@B63], [@B65]\].

Gene analysis indicated that *PHO85* encodes protein kinase highly homologous to Cdc28p (51% amino acid identity), the key cell cycle regulator in the yeast \[[@B62], [@B66]\]. But still the overexpression of one CDK does not compensate mutations in the other one. In view of the inviability of strains with *cdc28* mutations, Cdc28p is thought to be the main cell cycle kinase \[[@B67]\]. The presence of Pho85p is not necessary for viability, but this protein kinase assures normal metabolic and cell cycle dynamics reversion after stress \[[@B63]\].

Mutations *pho85* were firstly identified as recessive mutations of repressible APs\' constitutive synthesis in the sake yeast strains (original gene name---*PHO U*) and in the strains of Peterhoff Genetic Collection (originally---*ACP82*). Studying epistatic interactions between different *pho* mutations and mutations in gene *PHO85* revealed a negative role of CDK in *PHO5* expression regulation \[[@B12], [@B70], [@B71]\].

The role of protein kinase is not restricted by transcription regulation. A great number of *pho85* phenotypic effects were described \[[@B72], [@B69]\]. Yeast mutants *pho85* generally do not grow at 37°C, have abnormal cell morphology \[[@B73]\], are incapable of growing on nonfermentable carbon substrates (ethanol and glycerol), accumulate glycogen \[[@B74]\], are sensitive to aminoglycoside antibiotics \[[@B75]\], and cannot use proline as a sole nitrogen source \[[@B76]\]. Disruption of gene *PHO85* leads to forming phenotype of nuclear thermosensitivity (*ts*) and respiratory incompetence *\[rho-\]* affecting mitochondrial DNA \[[@B72]\]. The diploids heterozygous for *pho85* are characterized by defects of sporulation \[[@B77]\], that makes it difficult to analyze these features of the mutants. The *pho85* phenotypes\' research is of special interest because of homology between the yeast kinase Pho85p and the main mammalian neurogenesis protein kinase Cdk5p \[[@B78]\]. Mitochondria dysfunction is typical for many neurodegenerative diseases.

*PHO85* transcription does not depend on cell cycle stage, phosphate concentration, and *α*-factor. *PHO85*expression increases during sporulation, nitrogen depletion, and after heat shock. It is remarkable that the quantity of kinase monomers is constantly high in the cell.

Ogawa and coworkers showed that CDK Pho85p has a significant role in gene expression regulation \[[@B5]\]. They used flavopiridol, a specific inhibitor of kinases Cdc28p and Pho85p, to analyze its influence on genome expression. This confirmed Pho85p participation in transcription control of *PHO*-regulon, stress response genes (*CTT1, HSP12,* and*UBI4*) and other genes working in stationary phase \[[@B79]\].

2.6. CDK Structure {#sec2.6}
------------------

Cyclin-dependent protein kinase structure is extremely conservative. Take space structure of human Cdk2p as an example (<http://pdbwww1.sdsc.edu/pdb/explore.do?structureId=1B38>). Cdk2 consists of 11 subdomains, which are packed in two lobes with an active site cleft among. The N-terminus of Cdk2p is important for ATP binding and correct orientation of the molecule to the catalytic and protein-binding sites. The C-terminus determines binding of protein substrates. Amino acid residues which are localized in three short *β*-sheet sites between two lobes are other important players for Cdk2p catalysis \[[@B80]\]. The conservative PSTAIRE motive is necessary for cyclin binding in all CDKs, and Cdk2p is not a singularity \[[@B81]\].

The functional analysis of *PHO85* gene mutations was done in two laboratories \[[@B72], [@B82]\]. It is rather interesting to mention that CDK Pho85p needs no phosphorylation by other kinase in order to be active \[[@B83]\].

2.7. Pho85p Regulators {#sec2.7}
----------------------

### 2.7.1. Cyclins {#sec2.7.1}

The expression of cyclin genes is coordinated according to cell cycle phases. Cyclins play a double role in kinase activity regulation. On the one hand, programmed cyclin synthesis and degradation through the cell cycle leads to the well-timed kinase activation; on the other, cyclins determine substrate specific binding of kinase \[[@B84]\]. Cyclins are identified in many species, and it is shown that despite the specificity of cyclin-kinase interaction, CDK can be activated by different cyclins, and cyclins in its turn can activate different kinases. An exception to this rule applies yeast *S. cerevisiae*, and the principle of "one cyclin activates one kinase" was formed above them. All cyclins have conservative domain---cyclin box, which consists of 5 *α*-helixes \[[@B85]\]. It should be mentioned that the role of cyclins is not limited by cell cycle control.

The fact, gene PHO85 encodes CDK, and its mutations lead to different pleiotropic effects, engaged Pho85p cyclins, and substrates searches. Due to two-hybrid screening it is known that ten cyclins Pcl1p-Pcl10p can interact with Pho85p. PCL1--PCL10-deleted strains were constructed and characterized, on which ground Pcl1--Pcl10 cyclins were divided into two subfamilies: Pho80 subfamily (Pho80p, Pcl6p, Pcl7p, Pcl8p, and Pcl10p) and Pcl1, 2 subfamily (Pcl1p, Pcl2p, Pcl5p, Pcl9p, and Clg1) \[[@B86]\].

The Subfamily of Pho80p CyclinsCyclins of this family take part in metabolism control, such as stress response, temperature shock, nitrogen starvation, and stationary stage of growth.Pho80pPho80p was one of the first identified Pho85 cyclins. Unlike the other cyclins, *PHO80* expression is not changed through the cell cycle progression \[[@B87]\]. *PHO80* mutations have recessive inheritance and lead to constitutive synthesis of repressible acid phosphatases \[[@B88]\]. In *pho80* PGC yeast strains, two types of mutations were identified: recessive with constitutive synthesis of repressible acid phosphatases and semidominant mutations, which lead to the lack of repressible acid phosphatase expression phenotype \[[@B89]\]. *PHO80* expression is not governed by phosphate concentration, but still it does depend on Pho85p functionality. There are some contradictory data concerning Pho80p self-transcription regulation \[[@B89], [@B90]\]. *PHO80* transcription level is decreased during heat shock or nitrogen starvation, but during the stationary stage of growth, *PHO80* mRNA level is increased several times \[[@B33]\]. *PHO80* disruption has no lethal effect. There are some pleiotropic effects of *pho80* mutation, just to name few: permeability deoxythymidine monophosphate increase \[[@B91]\], vacuoles segregation defects \[[@B29], [@B30], [@B92], [@B93]\], decreased growth on nonfermentable carbon source containing medium \[[@B94]\], and methyl-methane sulphonate sensibility \[[@B95]\]. *PHO80* mutations lead to aminoglycosidic antibiotics resistance \[[@B33], [@B75]\]; *pho80* strains are characterized by ions K+, Mg2+, Zn2+, Ca2+, and Mn2+ sensibility increase \[[@B34], [@B96]\]. One of the most possible Pho80p partners is kinase Pho85p in all the above-mentioned processes and phenotypes. *PHO85* gene overdose compensates the effects of *pho80* deletion partially and shows allele-specific effect \[[@B94]\].Pho80p-Pho85p complex phosphorylates transcriptional factor bHLH-Pho4p \[[@B97], [@B98]\], as a result Pho4p stays in cytoplasm and is not capable of *PHO*-regulon genes activation on the medium with phosphate abundance \[[@B99]\]. *PHO80* overexpression leads to *PHO5* transcription inhibition restoration in *pho85* strains, which means that cyclin abundance can lead to nonspecific interactions with other kinases \[[@B99]\]. Pcl6p and Pcl7pPcl6p and Pcl7p cyclins have 46% identity. *PCL6* mRNA level is constant during all stages of cell cycle, but is increased during heat shock and nitrogen starvation and decreased in stationary phase of growth significantly, while *PCL7* mRNA level is increased by sixfold. *PCL6* insertional mutants have complete medium growth defects \[[@B33]\]. Pcl6p-Pho85p complex is able to phosphorylate Pho4p *in vitro*, but *in vivo* it is still unknown whether Pho4p is Pcl6p-Pho85p complex\'s substrate or not. Pcl6p and Pcl7p cyclin\'s role in metabolism control is rather contradictory. Some researchers have shown that Pcl6p-Pho85p complex regulates transcription of genes *PUT1* and *PUT2*, which encode proline utilization components \[[@B5], [@B76]\]. *PCL6* and *PCL7* mRNA increase during nitrogen starvation suits this hypothesis. But in another research work, it has been shown that Pcl6p-Pho85p and Pcl7p-Pho85p complexes control glycogen accumulation \[[@B100]\]. *PCL7* expression varies during cell cycle progression unlike other cyclin\'s genes of Pho80p subfamily. *PCL7* mRNA level is increased in the middle of S-phase of growth. Pcl7p-Pho85p complex activity is inhibited by Pho81p during phosphate starvation. Authors have considered a role of Pcl7p-Pho85p complex in cell cycle regulation \[[@B101]\]. Since cyclins Pcl7 and Pcl6 interact with common substrate, it is fair to assume that this substrate is Pho4p as in *PUT1,2* gene expression regulation and so in glycogen accumulation process. Pcl8p and Pcl10pOther members of Pho80p cyclin subfamily are Pcl8p and Pcl10p, which also form a complex with kinase Pho85p and phosphorylate glycogen synthase Gsy2p as *in vitro* so *in vivo*. Gsy2p phosphorylation prevents glycogen accumulation on phosphate-abundant medium \[[@B102]\]. As a conclusion of Pho80p subfamily cyclins description, it should be mentioned that protein interaction analysis by HMS-PCI (high-throughput mass spectrometric protein complex identification) method showed Pho85p interaction only with cyclins Pcl6p, Pcl7p, Pcl8p, and Pcl10p \[[@B103]\].

Pcl1/2p Subfamily CyclinsPcl1/2p subfamily cyclins are characterized by expression fluctuation during cell cycle progression. *PCL1/PCL2* expression pattern research has shown mRNA concentration decrease during heat shock, nitrogen starvation, and stationary stage of growth. Therefore, cyclins, that provide metabolic processes, are of key importance at stress conditions, rather than cyclins, which are necessary for cell cycle progression.*PCL1*, *PCL2*, and *PCL9* have maximum expression at early G~1~ phase *PCL5* mRNA level is constant during cell cycle progression but increases during nitrogen starvation, thermo shock, or stationary phase of growth \[[@B33]\]. *Pcl1/pcl1, pcl2/pcl2/, clg1/clg1, pcl5/pcl5, pcl9/pcl9* diploids, and *pho85*-deleted strains have common phenotype of abnormal cell morphology. Haploid cells of Δ*pho85* strains are characterized by large round cells with giant vacuoles. Homozygous *pho85/pho85* diploids also have some morphological defects: wide bud neck, granular cytoplasm, and elongated cells, but this phenotype is more noticeable on complete medium rather than on mineral \[[@B104]\]. One of the most interesting Pcl2p-Pho85p and Pcl9p-Pho85p substrates is protein Rvs167, which is homologous to mammalian amphiphysin-1. Rvs167p takes part in actin cytoskeleton regulation and cell survival after starvation \[[@B105]\]. *PCL9* transcription is activated by transcriptional factor Swi5p. Pcl9p-Pho85p complex is able to phosphorylate Pho4p *in vitro* and plays an important role in M/G~1~ checkpoint transition \[[@B106]\]. *PCL2* transcription activation also takes place after *α*-factor treatment and *PCL1*; *PCL9* mRNA level is decreased on the contrary. *α*-factor treatment leads to G1 stage arrest as far as *CLN1*, *CLN2* genes are low expressed and Cdc28p is inactive. Cell cycle progression is blocked, and Pcl2p-Pho85p is still functionally active.Clg1p is another member of Pcl1/2p subfamily with 27% homology to Pcl1p. *CLG1*-mutated strains have no visual phenotypic effects, and *CLG1* expression is constant during cell cycle progression \[[@B65]\]. *CLG1* mRNA level fluctuations take place during environment changes: it is decreased during amino acid and nitrogen starvation and is increased at stationary phase four times \[[@B33]\]. It is possible that Clg1p is the cyclin, which is responsible for the regulation of stationary phase genes by protein kinase Pho85p.Cyclins compete with each other for Pho85p kinase binding, so that cyclins expression fluctuations make the delicate regulation different depending on Pho85p processes possible.

Pho85p-Pho80p SubstratesCyclins determine the kinase substrate specificity. 19 Pho85p substrates were identified \[[@B62], [@B63]\]. Bound with different cyclins, protein kinase Pho85p takes part in the regulation of G1/S progression, cell polarity, *PHO*-regulon genes expression, and signal transduction \[[@B107]\]. Strains with *pho85* deletion are characterized by different phenotypic effects, such as constitutive synthesis of repressible acid phosphatases, slow growth with G~1~ arrest, glycogen accumulation, cell morphology changes, sporulation and cell polarization defects, irregular cell divisions, actin depolarization, endocytosis defects, and high frequency of thermosensitive and respiratory-deficient cells genesis \[[@B108]\].Respiratory-deficient phenotype is associated with mitochondrion functions defects. Mitochondria participation in different vital cellular processes dictates the necessity of delicate organelle function regulation existence according to the environmental changes. In cells of higher eukaryotic organisms, kea role in numerous stress response signals is played by transcription, factor p53 which blocks cell cycle progression and triggers apoptosis in many cell types, including neurons. Phosphorylated by Cdk5 transcription factor p53 is accumulated in nucleus, where it induces pro-apoptotic genes and mitochondria-mediated apoptosis in response to genotoxic or oxidative stress. Cdk5p prevents p53 ubiquitylation and downregulation \[[@B109]\]. Cdk5 is implicated in both development and disease of the mammalian central nervous system. Protein kinase Pho85p is a functional homologue of Cdk5p. The loss of Cdk5 in mice is perinatal lethal, and overactive Cdk5 induces apoptosis, meanwhile *pho85* mutations have no lethality effect. The existence of high conservativity in mitochondria functions regulation mechanisms permits to project revealed in yeast mechanisms to higher eukaryotes.Respiratory, carbon, and amino acid metabolisms take part in the regulation of mitochondrial functions in yeast \[[@B110]\]. An important role in mitochondria functions plays phosphate, but the consequences of phosphate metabolism defects on mitochondria functions in yeast are deficiently studied. Respiratory-deficient phenotype of *pho85* strains was thought to be a pleiotropic effect of the mutation \[[@B82]\]. Genetic analysis has shown that respiratory deficiency of *pho85* strains is estimated by nonnuclear determinant \[[@B68]\]. Respiratory deficiency of *pho85* strains can be the consequence of different reasons:point mutations or deletions of mitochondria DNA (mtDNA), as it was shown for *abf2*,*msh1*, *mip1*, and *rim1* mutants \[[@B111]\];mtDNA synthesis defects in the consequence of nucleotide pool changes (*adk1*, *sml1*) \[[@B112], [@B113]\];changes of protein quantity, which take part in mtDNA synthesis and compactization, because of nuclear genes expression level changes (*ILV5*, *ACO1*) or organelle protein transport defects (*tom20, pam17,*and*tom6*) \[[@B114], [@B115]\];mitochondria transport defects, which are determined by changes in mitochondria morphology (*mje1, pam18, ssc1, tim17, tim23, tim44, tom20, tom40, tom7,*and*tom70*) or by actin cytoskeleton structure or regulation changes (*act1*,*trp1*, *bni4*, *rvs167*, *sac6*, *sla1*, *prk1*, and *myo3*) \[[@B115], [@B116]\];mtDNA destabilization by mitochondrial mitochore structure changes or by mtDNA transport defects (*puf3*, *mdm31*, *mdm34*, *mmm1*, *mdm10*, and *mdm12*) \[[@B117]\];mitochondria membrane potential changes, as a consequence of membrane permeability defects (*crd1*, *atp10*, *atp11*, *atp12*, *atp25*, *fmc1*, *oxa1*, and *mir1*) \[[@B118]\].Respiratory-deficient cells of *pho85* strains appear on the medium with glucose when mitochondria functions are repressed. Mitochondria GFP marking has shown that respiratory-deficient phenotype of *pho85* strains is not a consequence of mitochondria morphology or transport defects \[[@B119], [@B120]\]. It was shown that *pho85*strains are characterized by high nuclear DNA mutation rate \[[@B121]\].mtDNA mutations frequency of active dividing cells depends neither on the moment of mutation appearance during cell divisions nor on replication regulation factors, mtDNA recombination, and segregation. These processes determine mutation fixation rate in multicopy pool of mtDNA. It was shown that *pho85* mutations lead to changes in expression pattern of genes *ABF2*, *ACO1*, *CCE1*, *MSH1-6*, *PIF1*,*MDM12*,*MMM1*,*MMM2*,*KGD1,*and*RPO41*, which encode mtDNA replication, reparation, and segregation proteins \[[@B5]\]. We have shown that *\[rho^0^\]* appearance in *pho85* strains is not a consequence of mutation accumulation, but is a result of mtDNA loss. Nucleoids loss of *pho85* strains is taking place on the medium with glucose and high concentration of phosphate. It was shown that in such environment respiratory-deficient cells have selective advantage \[[@B120]\].The loss of mtDNA is a dynamic process, and respiratory-deficient cell population consists of cells with full mtDNA loss *\[rho^0^\]* so of respiratory-deficient cells with low mtDNA copy number, which is not enough for respiration \[[@B122]\]. *\[rho^0^\]*colonies would not be able to revert on glycerol medium, but cells with low mtDNA copy number could reproduce normal mtDNA quantity, respiration, and growth on glycerol. We selected revertants, which had restored*pho85* strains respiration capability. Phenotype analysis and test for allelism revealed that respiration restoration of *pho85* strains is a consequence of *pho4*, *pho81*, *pho84,* and *pho87* mutations.In *pho85* strains, transcription factor Pho4p is always localized in nucleus, where it activates the expression of *PHO*-regulon genes, which encode phosphate permeases Pho84p and Pho87p, for example. As a result, an intracellular phosphate level is uncontrollably growing. Under such conditions, *pho85* cells with secondary mutations in genes encoding permeases Pho84p or Pho87p, in regulatory genes *PHO4* or *PHO81*or unidentified genes, get a selective advantage \[[@B120]\].Increase of intracellular phosphate concentration can lead to some negative effects, like plasmalemma or mitochondria membrane potential changes \[[@B123]\], PKA signal pathway activation \[[@B124]\], and so forth. Mutations preventing uncontrolled phosphate transport apparently normalize its cytoplasm concentration. Therefore, in the course of *Saccharomyces* evolution, regulatory networks which modify mitochondrion functions according to the changes not only of carbon or nitrogen source but also of changes in phosphate concentration has formed \[[@B120]\].

Pho85p and Cyclin\'s ChaperonesChaperones take part in protein kinases space structure organization. Yeast protein kinase Cdc28p form complexes with cyclins through some extra factors. Hsp90p\'s cochaperone Cdc37p is one of them. It was shown that Cdc37p is an important factor for Cdc28p-Cln2p and Cdc28p-Clb2p activation*in vitro*. Cdc37p has genetic interactions with 4 protein kinases: Cdc5p, Cdc7, Cdc15p, and Cak1p \[[@B125]\]. It is assumed that protein kinases stabilize inactive Cdc28p preparing it for cyclin binding \[[@B126]\]. Cdc37p and Cdc28p also have a genetic interaction, which was shown in synthetic lethality and suppressions analysis, but there are no evidences of Cdc37p and Cdc28p physical interactions. Two-hybrid analysis has shown physical interaction of N-terminus Cdc28p with C-terminus of Cdc37p, but still full-size Cdc28p protein did not interact with Cdc37p \[[@B125]\].Pho85p\'s chaperones have not been identified yet. We have selected different *pho85*missense mutants, which led to molecule conformation changes. One of these mutants had F82L substitution, which had led to Pho85p folding defects and constitutive synthesis of repressible acid phosphatases. Extragenic suppressions search of strains, which restore normal repressible acid phosphatases synthesis, have revealed a few genes. One of these suppressor genes is localized to a 2 cM interval from *PHO85*, like what*EGD1*gene does. *EGD1* encodes chaperone of Gal4p and of some ribosomal proteins \[[@B72]\]. It is fair enough to assume that Egd1p can regulate Pho85p conformation, but extra experiments are necessary for an exact conclusion.

### 2.7.2. Pho85p Inhibitors {#sec2.7.2}

Inhibitors and cyclins extend opposite effects. The majority of CDK\'s activity is controlled by cyclin binding. CDK inhibitors play a role of tumor suppressors and development regulators in mammalian cells so search of mechanisms it acts with is of great importance. Nowadays, three CDK inhibitors in yeast *S. Cerevisiae* are known:

1.  Far1p, which is activated by phosphorylation during alpha factor treatment and leads to cell cycle arrest at G~1~ stage by Cdc28p-Cln1p and Cdc28p-Cln2 inhibition \[[@B127]\];

2.  Sic1p, which inhibits Clb5p-Cdc28p and Clb6p-Cdc28p during G~1~ and Pcl2p-Pho85p; it also prevents DNA synthesis as long as cell passes through G~1~/S boundary \[[@B128]\];

3.  Pho81p is the only one identified Pho85p cyclin. *PHO81* mutations are characterized by two types of phenotype: one of them is recessive and leads to the lack of *PHO5* derepression, and other one is dominant and is characterized by constitutive synthesis of *PHO5* \[[@B5]\]. *PHO81* gene has been cloned \[[@B129]\].

*PHO81*promotor has Pho4p, Pho2p binding sites and negative regulatory sequence (NRS). NRS-localized deletions lead to *PHO81* expression increase at fourfold \[[@B130]\]. Main *PHO*-regulon regulatory proteins take part in *PHO81* transcription regulation. Pho81p contains 6 ankyrin repeats, that in mammalian homologues are used for cyclin-kinase complex attaching \[[@B131]\]. In case of Pho81p, it was shown that, ankyrin repeats do not influence the inhibitor-cyclin binding so inhibition itself. However, neither N-terminus nor C-terminus of the protein has an influence on interaction of cyclin-kinase complex with Pho81p. The 80 amino acid (645--724 aa) sequence was identified which is sufficient for cyclin-kinase complex interaction.

Activity regulation of a great number of proteins is determined by its localization. There are conformable proteins activators and Cln1p, Cln2p cyclins. Pho81p is predominantly localized in nucleus, but still it is can be situated in cytoplasm and endoplasmic membranes. Pho81p-Pho80p-Pho85p complex is constitutive, but kinase inhibition by inhibitor takes place only under phosphate starvation conditions. It is supposed that Pho81p inhibits kinase by means of cyclin binding, which leads to changes in 3(R121), 5(E154) helixes of cyclin, and kinase\'s PSTAIRE domain interaction \[[@B132]\].

Pho81p is also able to inhibit Pcl7p-Pho85p complex functioning during phosphate starvation. *PCL7* mRNA level is maximally increased during S-phase, so it is fair to assume that replication arrest is taking part according to the phosphate level \[[@B101]\].

So that Pho81p receives signals of phosphate concentration changes and transmits it to other proteins of signal network. Pho81p also interacts with adenylate cyclase Cdc35p. Adenylate cyclase controls PKA producing cAMP and is a part of RAS signal pathway, which in its turn takes part in glucose starvation signal pathway. Pho81p-Cdc37p interaction can lead to cAMP concentration changes in response to phosphate availability and transmit signal to PKA taking part in control of growth, proliferation, and other vital processes.

Pho81p-Cdc35p complex is localized in cytoplasmic membrane. It was shown that Pho81 can interact with a great number of other proteins, like mitotic growth component Emg1p or cortical cytoskeleton component Cof1p, but these complexes have cytoplasm localization \[[@B103]\]. It is possible that Pho81p influences Pho85p-cyclin complex functions according to phosphate concentration changes. Another Pho80p-Pho85p complex inhibitor is Spl2p. Spl2p and Pho81p have 27% identity \[[@B133]\].

Spl2p controls phosphorylation of other substrates except Pho4p, but*SPL2* transcription is regulated by Pho4p. *SPL2* mutations were identified as supressors of *plc1* mutants. *PLC1* gene encodes phosphoinositide-specific phospholipase C involved in regulating many cellular processes.

Proteolytic degradation also plays a significant role in kinase inhibitors regulation. Far1 and Sic1 target Cdc28p for degradation. Cdc28p inactivation leads to cell accumulation of inhibitors.

2.8. Transcription Regulation of *PHO* and ADE Genes by Metabolic Intermediates {#sec2.8}
-------------------------------------------------------------------------------

Recent studies have revealed that several key metabolic intermediates take part in phosphate and purine metabolism \[[@B134], [@B135]\]. A 5-phosphoribosyl-5-amino-4-imidazolecarboxamide (AICAR) and succinyl-AICAR belong to these regulatory molecules \[[@B136]\]. TF Pho2p is involved in the regulation of AICAR-dependent genes. During AICAR accumulation, the affinity of Pho2p to promotors of phosphate and purine metabolism genes also raises. It was shown that AICAR *in vitro* interacts with TF Pho2p and Pho4p in purine starvation conditions. *In vivo* Pinson and coauthors have revealed that AICAR can stimulate the formation of Pho2p-Pho4p and Pho2p-Bas1p complexes \[[@B44]\]. Thus, under the purine starvation conditions, TF Bas1p and Pho4p compete for Pho2p binding that provides the coordinated regulation of nucleotides biosynthesis and *P*~*i*~ uptake in cell.

It was shown that SAICAR affects only the formation of Pho2p-Bas1p complex and correspondingly the regulation of purine metabolism. Supposably the physiological reason of different cell response on the accumulation of AICAR and SAICAR appears to be the result of the adenylosuccinate lyase (ASL) function which metabolizes SAICAR in the inosin-5′-monophospate (IMP) and AMP biosynthesis *de novo* \[[@B137]\].

Another interesting example that illustrates cross-regulation of purine biosynthesis and phosphate metabolism is the constitutive transcription of *PHO5* on the background of *ado1* and *adk1*, encoding adenosine and adenylate kinases. In both cases, Pho4p is localized in nucleus even if the phosphate concentration is high \[[@B138]\].

Gauthier and coauthors have shown that Ado1p and Adk1p work upstream Pho81p, independently of phosphate concentration, but in response to concentration changes of ATP as the target product and AICAR as intermediate product \[[@B139]\].

Beside the regulation of *PHO*-genes by *P*~*i*~ and purine metabolism intermediates, some other mechanisms were also identified. There are models illustrating that *PHO*-genes expression also depends on the concentration of another *P*~*i*~ sources in the cell such as polyphosphates and inositol pyrophosphates.

2.9. Polyphosphates Metabolism {#sec2.9}
------------------------------

Polyphosphates are commonly used throughout almost all organisms as the reserve pool of *P*~*i*~ \[[@B3]\]. Polyphosphates are the linear polymers of phosphoric acid where the phosphate residues are linked by phosphoanhydride bonds as in ATP. Thus, polyphosphates are not only the reserve pool of phosphates but also play role as high-energy molecules. The number of phosphate residues can range from 3 to 1000. In yeast, 37% of all phosphate is accumulated as polyphosphate and 90% of polyphosphates, are localized in vacuoles.

It is known that the polymerization of phosphates is catalyzed by polyphosphates kinase in *Escherichia coli* (*E. coli*). The reverse reaction is the result of exopolyphosphatase function \[[@B1]\]. The major exopolyphosphatase in yeast *S. cerevisiae* is encoded by gene *PPX1* \[[@B140]\]. Ppx1p is localized in mitochondrial matrix, cytosol, and cell membrane. Ppx1p has restricted substrate specificity and can not cleave pyrophosphates, ATP, and cyclic forms of tripolyphosphates. Other enzymes were also discovered: exopolyphosphatases similar to Ppx1p localized in cell membrane and vacuoles (Ppx2p, Ppx3p) and the vacuolar endopolyphosphatase Ppn1p \[[@B140]--[@B143]\]. Many of the genes encoding enzymes of polyphosphates metabolism were discovered by the DNA Chip technology while searching the genes regulated by *PHO*-system.

By the analysis of genes expression levels on the medium with, high- and low-*P*~*i*~ concentrations, three genes were revealed in the wild-type and *PHO*-genes mutants: *PHM2*, *PHM3*, and *PHM4*, which had the expression levels similar to *PHO5* and *PHO84*. The homology of *PHM2*, *PHM3*, *PHM4,* and *PHM1*was also identified; *PHM1* showed the expression level similar to *PHO8* and *PHO86*. These genes encode integral proteins of vacuolar membrane, which form the heterotetrameric complex and regulate the activity of vacuolar H+-ATPase \[[@B144], [@B145]\]. Besides, genes encoding glycerol phosphatase Hor2p and ATP-phosphoribosyl transferase His1p are also regulated by the *P*~*i*~ concentration, and under starvation conditions their expression also increases along with *PHO5*, *PHO11*, *PHO12*, *PHO8,*and *PHM5*.

The AA sequences of Phm1p and Phm2p are identical for 58%. The N-end of the Phm1p, Phm2p, and Phm3p has a domain, which shows 33% homology with the N-end of Pho81p and Pho87p \[[@B18]\]. Strains *Δphm1*, *Δphm2*, *Δphm3*, *Δphm4*, and *Δphm1Δphm2* are viable and have the same growth dynamics as the wild-type strain. Meanwhile, such mutant cells demonstrate different levels of polyphosphate accumulation: *Δphm1* has low level of polyphosphate, and *Δphm2*leads to the significant decrease of polyphosphate level and to the reduction of polyphosphate chain length. In strains with double deletion *Δphm1Δphm2,*none of the polyphosphates are detected, which indicates the dubbing functions of Phm1p and Phm2p. Strains *Δphm3* and*Δphm4* do not contain polyphosphate also. Thus, Phm1p, 2p, 3p, and 4p play an important role in polyphosphate accumulation.

In yeast, polyphosphates serve as emergency stores of phosphate. When polyphosphate synthesis critically decreases, unassociated phosphates are accumulated in cell. Accordingly to this situation, the phosphate transport by phosphate permeases is going to be locked by the gene expression decrease. Thus, metabolisms of phosphates and polyphosphates have mutual mechanisms of regulation.

Such a scheme of mutual regulation also exists in bacteria *E. coli* and *Vibrio cholera*. Bacterial promotors of *ppk-ppx* operons have so named *pho*-box \[[@B5], [@B146]\], while phosphate starvation regulatory factor *phoB-phoR*docks*pho*-box and activates the polyphosphatases transcription \[[@B146]\].

Thus, the regulation of polyphosphate metabolism genes by phosphate concentration is a conservative feature of yeast and bacteria.

2.10. Inositol pyrophosphates: The New Form of Intracellular Signaling {#sec2.10}
----------------------------------------------------------------------

Inositol pyrophosphates are high-energy compounds involved in many biological functions of a cell. Inositol pyrophosphates take part in the regulation of such processes as vesicular transport, apoptosis, DNA reparation, telomere stability, and stress-motivated signaling, but exact mechanisms of this influence are still not clear \[[@B147]\]. Inositol pyrophosphates IP~7~ and IP~8~ are the most characterized molecules of this signaling system, which were found in all eukaryotic cells from amoeba to neurons of higher mammals. Pyrophosphorylation reactions constantly occur, so the concentration of IP~7~ and IP~8~ normally is high. A lot of substrates which are phosphorylated by IP~7~ were found in yeast and mammals \[[@B148]\]. The main advantage of phosphorylation by IP~7~ is the absence of necessity to special kinase functioning, like in ATP-dependent phosphorylation. IP~7~ phosphorylates substrates in direct way. The phosphorylated IP~7~ peptides are more resistant to phosphatases cleaving than peptides, which have been phosphorylated by means of ATP, because of another type of phosphate bond. By energy content, pyrophosphate bond of IP~7~ is equal to or even exceeds pyrophosphate bond of ATP, what indicates a great potential of these molecules in cell \[[@B149]\]. Pyrophosphorylation can be a new signaling system of eukaryotic cells \[[@B150]\].

The main players in inositol pyrophosphates biosynthesis are inositol hexakisphosphate kinases (IP6K) \[[@B151]\]. In yeast, *S. cerevisiae* IP6K are encoded by *KCS1*and*VIP1*genes. Strains Δ*kcs1* almost do not contain IP~7~ and IP~8~, but deletion of Ddp1p phosphatase gene (*DDP1*) on the Δ*kcs1*background suppresses this phenotype due to IP6K Vip1 \[[@B152]\]. IP6Ks Vip1 and Kcs1 synthesize different isomers of pyrophosphates. The existence of such differences in IP~7~ enantiomer biosynthesis might have a great physiological value. Thus, Lee with coauthors showed that IP~7~ which has been synthesized by kinase Vip1p represses Pho85p-Pho80p complex \[[@B153]\]. Meanwhile, the products of Kcs1p do not repress Pho85p-Pho80p. But the Kcs1p influence on *PHO*-regulon also exists as far as mutants *kcs1*are characterized by constitutive expression of*PHO5*and phosphate transport efficiency decrease \[[@B43]\]. Thus, the mechanisms of *PHO*-system regulation differ in the case of two IP~7~ enantiomers.

Despite the complicated phosphate cellular regulation, which includes the mechanisms of mutual control of orthophosphates, polyphosphates, and inositol pyrophosphates pathways, in order to regulate the cytoplasm phosphate concentration, Pho85p functions are of critical importance.

3. Conclusion {#sec3}
=============

Recent researches have revealed a significant role that nonprotein factors play in gene expression regulation in eukaryotic and prokaryotic cell. Especially, lots of data were obtained about regulatory function of different RNA molecules in response to environmental signals. The yeast *S. cerevisiae* have some well-studied samples of gene regulation by noncoding RNAs \[[@B154]--[@B156]\].

Three well-known asRNAs in yeast relate to phosphate metabolism. First, there is RNA molecule transcribed in antisense orientation from gene *PHO84* of the high-affinity permease of phosphates. This asRNA participates in the repression of its own gene in senescent cells \[[@B154]\]. Second, short asRNA is transcribed from gene *KCS1* in the presence of activator Pho4p and low phosphate concentration in medium. *KCS1* encodes structure of kinase involved in signal transduction about phosphate depletion. This asRNA blocks normal synthesis of Kcs1p that leads to the increase of Vip1p kinase activity. Vip1p competes with Kcs1p and intensifies derepression effect from phosphate depletion \[[@B157]\]. The third case is the one known sample of positive regulation by asRNA in the yeast. This asRNA (2400 n.) is transcribed in *PHO5* locus in repressive conditions of high phosphate, exceeds the *PHO5* ORF length (1400 n.), and binds the upstream region of gene *PHO5*. This binding leads to chromatin remodeling, histone removal from promotor DNA, and therefore *PHO5* transcription activation as soon as phosphate concentration goes down in the medium \[[@B158]\].

The latest analysis of cDNA libraries and RNA polymerase II binding sites mapping in *S. cerevisiae* genome revealed much more antisense RNAs with unknown functions. The future of expression control researches in eukaryotes is connected with studying the RNA role in yeast gene regulation, and *PHO*-regulon genes stand first in a queue.

![Gel-filtration of APs: (a) yeast strains 1G-P188 (PGK) and GRF18 (USA), cultivated in low-*P*~*i*~ medium; (b) strains 1G-P188 (PGK) and GRF18 (USA), cultivated in high-*P*~*i*~ medium.](ER2011-356093.001){#fig1}

![The pH dependence of enzyme activity: (a) AP1; (b) AP2 and AP3.](ER2011-356093.002){#fig2}
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![AP2 and AP3 enzyme activity at different KH~2~PO~4~ medium concentration. APs from yeast strains of PGK (St. Petersburg, Russia) and GRF18 (USA) were analyzed.](ER2011-356093.004){#fig4}
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